Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Letendre

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
AIDS and Behavior|November 2, 2011
HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherenceDavid J Moore, Carolina Posada, Mili Parikh, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 12, 2020
Heme oxygenase-1 promoter (GT) <sub></sub> polymorphism associates with HIV neurocognitive impairmentRolando Garza, Alexander J Gill, Brandon L Bastien, et al.
Psychiatry Research|December 3, 2013
"Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependencyMaría J Marquine, Jennifer E Iudicello, Erin E Morgan, et al.
Plos Pathogens|January 4, 2017
Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA PopulationsMichelli F Oliveira, Antoine Chaillon, Masato Nakazawa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 21, 2014
The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairmentMaría J Marquine, Anya Umlauf, Alexandra S Rooney, et al.
HIV/AIDS (Auckland, N.Z.)|May 21, 2016
Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioningAjay R Bharti, Steven Paul Woods, Ronald J Ellis, et al.
AIDS Research and Human Retroviruses|October 27, 2015
Complement Component 3 Is Associated with Metabolic Comorbidities in Older HIV-Positive AdultsAlex K Bryant, Pariya L Fazeli, Scott L Letendre, et al.
Plos One|November 13, 2012
Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohortDavid J Moore, Mollie J P Roediger, Lynn E Eberly, et al.
Mayo Clinic Proceedings|February 11, 1992
Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990L Letendre, H C Hoagland, S B Moore, et al.
Leukemia & Lymphoma|September 17, 2004
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombinMichelle A Elliott, Robert C Wolf, Christopher C Hook, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
AIDS and Behavior|November 2, 2011
HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherenceDavid J Moore, Carolina Posada, Mili Parikh, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 12, 2020
Heme oxygenase-1 promoter (GT) <sub></sub> polymorphism associates with HIV neurocognitive impairmentRolando Garza, Alexander J Gill, Brandon L Bastien, et al.
Psychiatry Research|December 3, 2013
"Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependencyMaría J Marquine, Jennifer E Iudicello, Erin E Morgan, et al.
Plos Pathogens|January 4, 2017
Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA PopulationsMichelli F Oliveira, Antoine Chaillon, Masato Nakazawa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 21, 2014
The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairmentMaría J Marquine, Anya Umlauf, Alexandra S Rooney, et al.
HIV/AIDS (Auckland, N.Z.)|May 21, 2016
Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioningAjay R Bharti, Steven Paul Woods, Ronald J Ellis, et al.
AIDS Research and Human Retroviruses|October 27, 2015
Complement Component 3 Is Associated with Metabolic Comorbidities in Older HIV-Positive AdultsAlex K Bryant, Pariya L Fazeli, Scott L Letendre, et al.
Plos One|November 13, 2012
Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohortDavid J Moore, Mollie J P Roediger, Lynn E Eberly, et al.
Mayo Clinic Proceedings|February 11, 1992
Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990L Letendre, H C Hoagland, S B Moore, et al.
Leukemia & Lymphoma|September 17, 2004
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombinMichelle A Elliott, Robert C Wolf, Christopher C Hook, et al.
Pageof 25